[{"NetIncomeLoss_1_Q2_USD":-35929000.0,"NetIncomeLossAttributableToNoncontrollingInterest_1_Q2_USD":-36000.0,"MinorityInterestDecreaseFromRedemptions_2_Q2_USD":339000.0,"OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_2_Q2_USD":-150000.0,"OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_1_Q2_USD":-1783000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":34046000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":17927000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":127519000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":138977000.0,"InterestAndOtherIncome_2_Q2_USD":3480000.0,"InterestAndOtherIncome_1_Q2_USD":1932000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_2_Q2_USD":-97000.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_1_Q2_USD":-36000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-1653000.0,"NetIncomeLossAttributableToNoncontrollingInterest_2_Q2_USD":-97000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q2_USD":1500000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q2_USD":142526000.0,"StockIssuedDuringPeriodValueNewIssues_2_Q2_USD":142526000.0,"GoodwillImpairmentLoss_2_Q2_USD":0.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":0.0,"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q2_USD":19221000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":6556000.0,"AssetsCurrent_0_Q2_USD":679400000.0,"OtherNoncashIncomeExpense_2_Q2_USD":0.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":14964567.0,"StockIssuedDuringPeriodValueShareBasedCompensation_2_Q2_USD":852000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q2_USD":443000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":6468000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":197410000.0,"Assets_0_Q2_USD":894659000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":101328000.0,"ShareBasedCompensation_2_Q2_USD":12384000.0,"OperatingLeaseLiability_0_Q2_USD":42610000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":646000.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":178890000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":2717000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":83002000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":41523000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":54966000.0,"MinorityInterest_0_Q2_USD":-251000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_Q2_USD":19000.0,"LettersOfCreditOutstandingAmount_0_Q2_USD":1500000.0,"AccountsReceivableNetCurrent_0_Q2_USD":5618000.0,"CommonStockValue_0_Q2_USD":1410000.0,"GainLossOnTerminationOfLease_2_Q2_USD":0.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q2_USD":0.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_Q2_USD":1559000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":2639000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":392000.0,"IncreaseDecreaseInEmployeeRelatedLiabilities_2_Q2_USD":-248000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":144565000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_2_Q2_USD":151839000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-78046000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-33754000.0,"AccruedEmployeeBenefitsCurrent_0_Q2_USD":13332000.0,"OtherAssetsNoncurrent_0_Q2_USD":13814000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":467443000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":39234000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":1247527000.0,"DebtSecuritiesAvailableForSaleRealizedLoss_2_Q2_USD":0.0,"DebtSecuritiesAvailableForSaleRealizedLoss_1_Q2_USD":0.0,"Liabilities_0_Q2_USD":383453000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_2_Q2_USD":1307000.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_2_Q2_USD":345000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_0_Q2_USD":197410000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q2_USD":-33790000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":73501000.0,"InterestReceivableCurrent_0_Q2_USD":534000.0,"VariableLeaseCost_1_Q2_USD":500000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-735827000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":387015000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":-31291000.0,"RestrictedCashNoncurrent_0_Q2_USD":1500000.0,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":43580000.0,"IncreaseDecreaseInAccruedInterestReceivableNet_2_Q2_USD":-148000.0,"PaymentsToAcquireAdditionalInterestInSubsidiaries_2_Q2_USD":237000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":979000.0,"Goodwill_0_Q2_USD":39318000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2_Q2_USD":455000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":6764000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2_Q2_USD":12384000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_Q2_USD":150000.0,"VariableLeaseCost_2_Q2_USD":1000000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q2_USD":1783000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":6390000.0,"LiabilitiesCurrent_0_Q2_USD":93942000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":468943000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":8395000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q2_USD":53219000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.062,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q2_USD":511206000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_2_Q2_USD":1187000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q2_USD":1187000.0,"OperatingLeasePayments_2_Q2_USD":3100000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q2_USD":6578000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":1977000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":33907000.0,"NetIncomeLoss_2_Q2_USD":-78842000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":141103000.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":1187000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":1146000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":6694000.0,"AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_0_Q2_USD":0.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":12356000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":6694000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":7763000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":34629000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":21553000.0,"OperatingIncomeLoss_2_Q2_USD":-82419000.0,"OperatingIncomeLoss_1_Q2_USD":-37897000.0,"OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale_2_Q2_USD":0.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q2_USD":197410000.0,"ProceedsFromIssuanceInitialPublicOffering_2_Q2_USD":0.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":61389000.0,"PreferredStockValue_0_Q2_USD":0.0,"OperatingLeaseCost_2_Q2_USD":5100000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":196431000.0,"OperatingLeaseCost_1_Q2_USD":2600000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":12384000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":6764000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":3376000.0,"OperatingExpenses_2_Q2_USD":117048000.0,"OperatingExpenses_1_Q2_USD":59450000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2_Q2_USD":0.0,"RestrictedCashAndCashEquivalentsAtCarryingValue_0_Q2_USD":0.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-0.62,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.26,"ProfitLoss_1_Q2_USD":-35965000.0,"ProfitLoss_2_Q2_USD":-78939000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":6055000.0,"StockholdersEquity_0_Q2_USD":511457000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q2_USD":237644000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":894659000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_2_Q2_USD":-78143000.0,"Ticker":"SGMO","CIK":"1001233","name":"SANGAMO THERAPEUTICS, INC","OfficialName":"Sangamo Therapeutics Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"750923571.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20200805"}]